Identifying patients suitable for same day discharge after Transcatheter Aortic Valve Implantation (NORTH SHORE DAY STAY TAVI)

Not Applicable

Recruiting

• Conditions: Aortic Stenosis; Transcatheter Aortic Valve Implantation; Cardiovascular - Other cardiovascular diseases; Public Health - Health service research

• Registration Number: ACTRN12624000571572
• Lead Sponsor: Department of Cardiology, Royal North Shore Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-05-06
• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 59

Inclusion Criteria

All patients undergoing elective, transfemoral TAVI procedures

Exclusion Criteria

- Inpatient or non-elective TAVI
- Non-transfemoral access

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Composite endpoint of all-cause mortality, stroke, major bleeding, major vascular complication, new renal replacement therapy and high-grade atrioventricular block[Assessment of the composite endpoint at index hospitalisation will occur via review of medical records by the Research Team.<br><br>Assessment of the composite endpoint at 30 days after TAVI will occur via a 15-30 minute in-person clinic review or telephone interview (if there are logistic and travel constraints such as regional or interstate patients). There will also be corroboration of data collected from the patient via review of medical records by the Research team. Review by the patient's regular Cardiologist and repeat transthoracic echocardiogram at 30 days after TAVI required by the study is part of standard care. <br><br>Statistical methods for assessment will be using the area under the receiver operating characteristic curve (AUROC) for the composite endpoint. Index hospitalization<br>30 days after TAVI procedure]